Ex-Palantir team bags $12M seed to build the AI operating system pharma has been missing
Summary
Perceptic has emerged from stealth with a $12 million seed round led by Accel. The company is building an AI operating system that connects the full drug development lifecycle, from discovery through clinical development. Its platform targets the fragmentation that slows pharma teams by unifying data, context, and decision-making across departments. Perceptic already has paid production deployments at several pharma companies, biotechs, and CROs, including CSL. The funding will support engineering hires and expansion of existing deployments.
Funding
Amount
$12.0M
Total raised
Date
May 27, 2026
Announcement date
Investors
Accel, CSL
Lead investors
Company
perceptic.com
Funded company
Classifications
industries
No industries detected
applications
Business Intelligence
AskAI Classifications
Labels
SaaS
Enterprise Software
AI/ML Platform
Linked Companies
Perceptic
$1M to $5M